RHYTHM PHARMACEUTICALS, INC. Increase (Decrease) in Due to Related Parties, Current
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Increase (Decrease) in Due to Related Parties, Current of -$105.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2020-03-02
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in due to related parties, current for the quarter ending 2017-12-31 was $0.00.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in due to related parties, current for the quarter ending 2017-09-30 was $0.00.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in due to related parties, current for the quarter ending 2017-06-30 was $0.00.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in due to related parties, current for the quarter ending 2017-03-31 was -$105.00K.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in due to related parties, current for fiscal 2017 was -$105.00K.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in due to related parties, current for fiscal 2016 was -$470.00K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month | Increase (Decrease) in Due to Related Parties, Current 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | -$105.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | -$105.00K 10-Q · filed 2018-11-09 | -$714.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$105.00K 10-Q · filed 2018-08-08 | -$714.00K derived: sum of 3 quarters · filed 2019-03-08 | |
| 2017-03-31 | -$105.00K 10-Q · filed 2018-05-14 | -$714.00K derived: sum of 2 quarters · filed 2019-03-08 | ||
| 2016-12-31 | -$609.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$470.00K 10-K · filed 2019-03-08 | ||
| 2016-09-30 | $139.00K 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | $575.00K 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |